The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Mega-Mergers: Largest Recent M&A Transactions

By The Online Investor Staff, updated Wed., May. 27, 5:23 PM

Slide #1. AbbVie Allergan plc

Acquirer: AbbVie (ABBV)
Acquiree: Allergan plc (AGN)
Details: Allergan plc (NYSE: AGN) ("Allergan") announced that AbbVie has now completed the acquisition of Allergan pursuant to a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the "Scheme"), which became effective earlier today, May 8, 2020.

AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

AbbVie SEC Filing Email Alerts Service


Open the ABBV Page at The Online Investor »

AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.

AbbVie SEC Filing Email Alerts Service


Open the AGN Page at The Online Investor »

Company Name:  AbbVie Inc
Stock buyback:  ABBV buyback
Website:  www.abbvie.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding ABBV:  122
Total Market Value Held by ETFs:  $15.62B
Total Market Capitalization:  $133.96B
% of Market Cap. Held by ETFs:  11.66%
Company Name:  Allergan PLC
Stock buyback:  AGN buyback
Website:  www.allergan.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding AGN:  28
Total Market Value Held by ETFs:  $3.88B
Total Market Capitalization:  $63.57B
% of Market Cap. Held by ETFs:  6.10%
 

May 27, 2020    5:23 PM Eastern
Quotes delayed 20 minutes


Mega-Mergers | www.TheOnlineInvestor.com | Copyright © 1998 - 2020, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.